The Latest Headlines at American Banking and Market News
Banc of California, Inc. (NYSE:BANC) Shares Bought by New York State Common Retirement Fund
New York State Common Retirement Fund grew its holdings in shares of Banc of California, Inc. (NYSE:BANC – Free Report) by 193.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission... More of this article »
New York State Common Retirement Fund Cuts Stock Position in Equity Commonwealth (NYSE:EQC)
New York State Common Retirement Fund lessened its stake in shares of Equity Commonwealth (NYSE:EQC – Free Report) by 12.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission... More of this article »
Asana, Inc. (NYSE:ASAN) Stake Lifted by New York State Common Retirement Fund
New York State Common Retirement Fund increased its stake in Asana, Inc. (NYSE:ASAN – Free Report) by 22.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).... More of this article »
New York State Common Retirement Fund Buys 396 Shares of City Holding (NASDAQ:CHCO)
New York State Common Retirement Fund boosted its stake in City Holding (NASDAQ:CHCO – Free Report) by 6.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The... More of this article »
New York State Common Retirement Fund Boosts Holdings in Laureate Education, Inc. (NASDAQ:LAUR)
New York State Common Retirement Fund boosted its position in shares of Laureate Education, Inc. (NASDAQ:LAUR – Free Report) by 5.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange... More of this article »
New York State Common Retirement Fund Has $730,000 Holdings in AdvanSix Inc. (NYSE:ASIX)
New York State Common Retirement Fund increased its position in AdvanSix Inc. (NYSE:ASIX – Free Report) by 2.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 24,364 shares of the... More of this article »
New York State Common Retirement Fund Has $735,000 Stock Position in JetBlue Airways Co. (NASDAQ:JBLU)
New York State Common Retirement Fund lowered its holdings in shares of JetBlue Airways Co. (NASDAQ:JBLU – Free Report) by 98.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission... More of this article »
New York State Common Retirement Fund Acquires 609 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)
New York State Common Retirement Fund raised its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) by 1.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC.... More of this article »
FinVolution Group (NYSE:FINV) Shares Sold by New York State Common Retirement Fund
New York State Common Retirement Fund cut its stake in shares of FinVolution Group (NYSE:FINV – Free Report) by 3.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange... More of this article »
New York State Common Retirement Fund Sells 5,609,033 Shares of Spirit Airlines, Inc. (NYSE:SAVE)
New York State Common Retirement Fund trimmed its position in shares of Spirit Airlines, Inc. (NYSE:SAVE – Free Report) by 99.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange... More of this article »
UWM (NYSE:UWMC) Earns “Market Perform” Rating from Keefe, Bruyette & Woods
Keefe, Bruyette & Woods reiterated their market perform rating on shares of UWM (NYSE:UWMC – Free Report) in a report issued on Friday morning, Benzinga reports. They currently have a $7.00 target price on the stock, up... More of this article »
Fate Therapeutics (NASDAQ:FATE) Price Target Cut to $4.00 by Analysts at Piper Sandler
Fate Therapeutics (NASDAQ:FATE – Free Report) had its target price decreased by Piper Sandler from $7.00 to $4.00 in a research note published on Friday, Benzinga reports. Piper Sandler currently has a neutral rating on the biopharmaceutical... More of this article »
Insulet (NASDAQ:PODD) Price Target Increased to $260.00 by Analysts at Jefferies Financial Group
Insulet (NASDAQ:PODD – Free Report) had its target price increased by Jefferies Financial Group from $255.00 to $260.00 in a research report sent to investors on Friday morning, Benzinga reports. They currently have a buy rating... More of this article »